These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9551705)

  • 1. Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration.
    Möllmann H; Wagner M; Meibohm B; Hochhaus G; Barth J; Stöckmann R; Krieg M; Weisser H; Falcoz C; Derendorf H
    Eur J Clin Pharmacol; 1998 Feb; 53(6):459-67. PubMed ID: 9551705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
    Möllmann H; Wagner M; Krishnaswami S; Dimova H; Tang Y; Falcoz C; Daley-Yates PT; Krieg M; Stöckmann R; Barth J; Lawlor C; Möllmann AC; Derendorf H; Hochhaus G
    J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between systemic exposure to fluticasone propionate and cortisol reduction in healthy male volunteers.
    Mackie AE; Bye A
    Clin Pharmacokinet; 2000; 39 Suppl 1():47-54. PubMed ID: 11140433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic modeling of cortisol reduction after inhaled administration of fluticasone propionate.
    Rohatagi S; Bye A; Falcoz C; Mackie AE; Meibohm B; Möllmann H; Derendorf H
    J Clin Pharmacol; 1996 Oct; 36(10):938-41. PubMed ID: 8930781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler.
    Grahnén A; Jansson B; Brundin RM; Ling-Andersson A; Lönnebo A; Johansson M; Eckernäs SA
    Eur J Clin Pharmacol; 1997; 52(4):261-7. PubMed ID: 9248762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma.
    Falcoz C; Horton J; Mackie AE; Harding SM; Daley-Yates PT
    Clin Pharmacokinet; 2000; 39 Suppl 1():31-7. PubMed ID: 11140431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
    Daley-Yates PT; Deans A; Mehta R; Sousa AR
    Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions.
    Kirby S; Falcoz C; Daniel MJ; Milleri S; Squassante L; Ziviani L; Ventresca GP
    Eur J Clin Pharmacol; 2001; 56(11):781-91. PubMed ID: 11294367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
    Brutsche MH; Brutsche IC; Munawar M; Langley SJ; Masterson CM; Daley-Yates PT; Brown R; Custovic A; Woodcock A
    Lancet; 2000 Aug; 356(9229):556-61. PubMed ID: 10950233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung.
    Minto C; Li B; Tattam B; Brown K; Seale JP; Donnelly R
    Br J Clin Pharmacol; 2000 Aug; 50(2):116-24. PubMed ID: 10930963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the systemic availability of fluticasone propionate in healthy volunteers and patients with asthma.
    Daley-Yates PT; Tournant J; Kunka RL
    Clin Pharmacokinet; 2000; 39 Suppl 1():39-45. PubMed ID: 11140432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in healthy volunteers.
    Mackie AE; McDowall JE; Falcoz C; Ventresca P; Bye A; Daley-Yates PT
    Clin Pharmacokinet; 2000; 39 Suppl 1():23-30. PubMed ID: 11140430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenous fluticasone propionate in healthy subjects.
    Mackie AE; Ventresca GP; Fuller RW; Bye A
    Br J Clin Pharmacol; 1996 Jun; 41(6):539-42. PubMed ID: 8799519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects.
    Thorsson L; Dahlström K; Edsbäcker S; Källén A; Paulson J; Wirén JE
    Br J Clin Pharmacol; 1997 Feb; 43(2):155-61. PubMed ID: 9131947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers.
    Lönnebo A; Grahnén A; Jansson B; Brundin RM; Ling-Andersson A; Eckernäs SA
    Eur J Clin Pharmacol; 1996; 49(6):459-63. PubMed ID: 8706770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
    Fowler SJ; Orr LC; Wilson AM; Sims EJ; Lipworth BJ
    Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.
    Dempsey OJ; Wilson AM; Coutie WJ; Lipworth BJ
    Chest; 1999 Oct; 116(4):935-40. PubMed ID: 10531156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluticasone furoate, a novel inhaled corticosteroid, demonstrates prolonged lung absorption kinetics in man compared with inhaled fluticasone propionate.
    Allen A; Bareille PJ; Rousell VM
    Clin Pharmacokinet; 2013 Jan; 52(1):37-42. PubMed ID: 23184737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.
    Xu J; Nave R; Lahu G; Derom E; Derendorf H
    J Clin Pharmacol; 2010 Oct; 50(10):1118-27. PubMed ID: 20150524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant.
    Mackie AE; McDowall JE; Ventresca P; Bye A; Falcoz C; Daley-Yates PT
    Clin Pharmacokinet; 2000; 39 Suppl 1():17-22. PubMed ID: 11140429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.